This work assessed the feasibility of quantitative parameters derived from APT and IVIM in the predicting the recurrence of early stage Hepatocellular carcinoma (HCC) treated with transcatheter arterial chemoembolization (TACE). We find that combined quantitative parameters of APT and IVIM can be used to predict the recurrence. Therefore, APT and IVIM can be used as imaging biomarkers to predict the recurrence of early stage of HCC after TACE treatment.
This abstract and the presentation materials are available to members only; a login is required.